Actions of endothelin-1, 2, and 3 in the microvasculature of bone

Journal of Orthopaedic Research

Volumn 16, Issue 3, 1998, Pages 340-347

  Briggs, P J ^a   Moran, C G ^a   Wood, M B ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMECHANICS; CALCIUM; MATHEMATICAL MODELS; MUSCLE; MUSCULOSKELETAL SYSTEM; PROTEINS; TISSUE;

CONSTRICTION; ENDOTHELIN; MICROVASCULATURE OF BONE; REPERFUSION; VASOCONSTRICTOR RESPONSES;

BONE;

ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN 3; ENDOTHELIN RECEPTOR; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE BLOOD FLOW; CONTROLLED STUDY; DOG; HYPOXIA; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTILITY; TACHYPHYLAXIS; TIBIA; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE;

EID: 0032077649     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.1100160310     Document Type: Article

References (33)

1. 1 Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S: Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730–732, 1990
2. 2 Auguet M, Delaflotte S, Chabrier PE, Pirotzky E, Clostre F, Braquet P, Endothelin and Ca++ agonist Bay K 8644: different vasoconstrictive properties. Biochem Biophys Res Commun 156: 186–192, 1988
3. 3 Baydoun AR, Peers SH, Cirino G, Woodward B: Vasodilator action of endothelin‐1 in the perfused rat heart. J Cardiovasc Pharmacol 15: 759–763, 1990
4. 4 Blackburn K, Highsmith RF: Nickel inhibits endothelin‐induced contractions of vascular smooth muscle. Am J Physiol 258: C1025–C1030, 1990
5. 5 Brinker MR, Lippton HL, Cook SD, Hyman AL: Pharmacological regulation of the circulation of bone. J Bone Joint Surg [Am] 72: 964–975, 1990
6. 6 Cairns HS, Rogerson ME, Fairbanks LD, Neild GH, Westwick J: Endothelin induces an increase in renal vascular resistance and a fall in glomerular filtration rate in the rabbit isolated perfused kidney. Br Pharmacol 98: 155–160, 1989
7. 7 Cerra FB, Raza S, Andres GA, Siegel JH: The endothelial damage of pulsatile renal preservation and its relationship to perfusion pressure and colloid osmotic pressure, Surgery 81: 534–541, 1977
8. 8 Davis TRC, Wood MB: Endothelial control of long bone vascular resistance. J Orthop Res 10: 344–349, 1992
9. 9 Davis TRC, Wood MB: The effects of acidosis and alkalosis on long bone vascular resistance. J Orthop Res 11: 834–839, 1993
10. 10 Dean MT, Wood MB, Vanhoutte PM: Antagonist drugs and bone vascular smooth muscle. J Orthop Res 10: 104–111, 1992
11. 11 Driessens M, Vanhoutte PM: Vascular reactivity of the isolated tibia of the dog. Am J Physiol 236: H904–H908, 1979
12. 12 Eglen RM. Michel AD, Sharif NA, Swank SR, Whiting RL: The pharmacological properties of the peptide, endothelin. Br J Pharmacol 97: 1297–1307, 1989
13. 13 Goto K, Kasuya Y, Matsuki N, Takuwa Y, Kurihara H, Ishikawa T, Kimura S, Yanagisawa M, Masaki T: Endothelin activates the dihydropyridine‐sensitive voltage‐dependent Ca2+ channel in vascular smooth muscle. Proc Natl Acad Sci U S A 86: 3915–3918, 1989
14. 14 Gross PM, Heistad DD, Marcus ML: Neurohumoral regulation of blood flow to bones and marrow. Am J Physiol 237: H440–H448, 1979
15. 15 Ihara M, Noguchi K, Saeki T, Fukuroda T, Tsuchida S, Kimura S, Fukami T, Ishikawa K, Nishikibe M, Yano M: Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci 50: 247–255, 1992
16. 16 Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T: The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A 86: 2863–2867, 1989
17. 17 Johnson PC: Myogenic mechanisms of blood flow regulation. In: Vasodilation, pp 255–262. Ed by PM Vanhoutte and I Leusen. New York, Raven Press, 1981
18. 18 Kon V, Yoshioka T, Fogo A, Ichikawa I: Endothelin may be the vasoconstrictor causing the persistent glomerular hypoperfusion in post ischaemic kidneys [abstract]. Kidney int 35: 410, 1989
19. 19 Madeddu P, Yang X‐P, Anania V, Troffa C, Pazzola A, Soro A, Manunta P, Tonolo G, Demontis MP, Varoni MV, Melis MG, Glorioso N: Efficacy of nifedipine to prevent systemic and renal vasoconstrictor effects of endothelin. Am J Physiol 259: F304–F311, 1990
20. 20 Maulik N, Liu X, Subramahian R, Das DK: Release of endothelin during reperfusion of ischemic myocardium: ET‐1 release from reperfused heart. Am J Cardiovasc Pathol 4: 133–144, 1992
21. 21 Moran CG, Wood MB: Failure of perfusion with oxygenated Krebs‐Ringer solution to preserve the eccrine function of vascular endothelium in bone. J Orthop Res 10: 813–817, 1992
22. 22 Ohlstein EH, Horohonich S, Hay DWP: Cellular mechanisms of endothelin in rabbit aorta. J Pharmacol Exp Ther 250: 548–555, 1989
23. 23 Rubanyi GM: Endothelium‐derived vasoconstrictor factors. In: Endothelial Cells, vol III, pp 61–70. Ed by US Ryan. Boca Raton, CRC Press, 1988
24. 24 Shim SS: Physiology of blood circulation of bone. J Bone Joint Surg [Am] 50: 812–824, 1968
25. 25 Simonson MS, Osanai T, Dunn MJ: Endothelin isopeptides evoke Ca2+ signaling and oscillations of cytosolic free [Ca2+] in human mesangial cells. Biochim Biophys Acta 1055: 63–68, 1990
26. 26 Simonson MS, Dunn MJ: The molecular mechanisms of cardiovascular and renal regulation by endothelin peptides. J Lab Clin Med 119: 622–639, 1992
27. 27 Vigne P, Lazdunski M, Frelin C: The inotropic effect of endothelin‐1 on rat atria involves hydrolysis of phosphatidylinositol. FEBS Lett 249: 143–146, 1989
28. 28 Warner TD, de Nucci G, Vane JR: Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat. Eur J Pharmacol 159: 325–326, 1989
29. 29 Watanabe T, Suzuki N, Shimamoto N, Fujino M, Imada A: Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res 69: 370–377, 1991
30. 30 Wilkes BM, Ruston AS, Mento P, Giraldi E, Hart D, Vander Molen M, Barnett R, Nord EP: Characterization of endothelin 1 receptor and signal transduction mechanisms in rat medullary interstitial cells. Am J Physiol 260: F579–F589, 1991
31. 31 Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelium cells. Nature 332: 411–415, 1988
32. 32 Yanagisawa M, Masaki T: Endothelin, a novel endothelium‐derived peptide: pharmacological activities, regulation and possible roles in cardiovascular control. Biochem Pharmacol 38: 1877–1883, 1989
33. 33 Ye Z, Wood MB, Vanhoutte PM: Alpha‐adrenergic receptor responsiveness in vascular smooth muscle of canine bone. Clin Orthop 287: 286–291, 1993